摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-ethyl-5-amino-6,7,8-trifluoro-4-oxo-1,4-dihydro quinoline-3-carboxylic acid | 131683-97-1

中文名称
——
中文别名
——
英文名称
1-ethyl-5-amino-6,7,8-trifluoro-4-oxo-1,4-dihydro quinoline-3-carboxylic acid
英文别名
5-amino-1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;1-ethyl-5-amino-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid;5-amino-1-ethyl-6,7,8-trifluoro-4-oxoquinoline-3-carboxylic acid
1-ethyl-5-amino-6,7,8-trifluoro-4-oxo-1,4-dihydro quinoline-3-carboxylic acid化学式
CAS
131683-97-1
化学式
C12H9F3N2O3
mdl
MFCD05857968
分子量
286.21
InChiKey
QBPREFHFYMKGGJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    288-295 °C (decomp)
  • 沸点:
    481.9±45.0 °C(Predicted)
  • 密度:
    1.591±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    83.6
  • 氢给体数:
    2
  • 氢受体数:
    8

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-甲基哌嗪1-ethyl-5-amino-6,7,8-trifluoro-4-oxo-1,4-dihydro quinoline-3-carboxylic acid乙腈 为溶剂, 以91%的产率得到5-Amino-1-ethyl-6,8-difluoro-7-(3-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
    参考文献:
    名称:
    Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship
    摘要:
    A series of 5-amino- and 5-hydroxyquinolone antibacterials substituted at C7 with a select group of common piperazinyl and 3-aminopyrrolidinyl side chains was prepared. These 5-substituted derivatives were compared to the analogous 5-hydrogen compounds for antiinfective activity by using DNA gyrase inhibition, minimum inhibitory concentrations against a variety of bacteria, and in vivo efficacy in the mouse infection model. The influence on the structure-activity relationships of varied substituents at C8 (H, F, Cl) and Ni (ethyl, cyclopropyl, difluorophenyl) was also studied. The results showed that several of the structure-activity conclusions regarding side-chain bulk at C7, the effect of halogen at C8, and the effect of the C5-amino group were greatly influenced by the choice of the N1-substituent. Several outstanding broad spectrum quinolones were identified in this work. In particular, the spectrum and potency of the 7-piperazinyl quinolones could be greatly enhanced by the judicious choice of C5-, C8-, and N1-substitutents.
    DOI:
    10.1021/jm00107a039
  • 作为产物:
    描述:
    2,3,4,5-四氟苯甲酸 在 RaNi 盐酸正丁基锂 、 dipyridyl 、 草酰氯potassium tert-butylate氢气乙酸酐N,N-二甲基甲酰胺 作用下, 以 四氢呋喃乙醇二氯甲烷叔丁醇 为溶剂, -78.0~60.0 ℃ 、137.9 kPa 条件下, 反应 43.5h, 生成 1-ethyl-5-amino-6,7,8-trifluoro-4-oxo-1,4-dihydro quinoline-3-carboxylic acid
    参考文献:
    名称:
    Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship
    摘要:
    A series of 5-amino- and 5-hydroxyquinolone antibacterials substituted at C7 with a select group of common piperazinyl and 3-aminopyrrolidinyl side chains was prepared. These 5-substituted derivatives were compared to the analogous 5-hydrogen compounds for antiinfective activity by using DNA gyrase inhibition, minimum inhibitory concentrations against a variety of bacteria, and in vivo efficacy in the mouse infection model. The influence on the structure-activity relationships of varied substituents at C8 (H, F, Cl) and Ni (ethyl, cyclopropyl, difluorophenyl) was also studied. The results showed that several of the structure-activity conclusions regarding side-chain bulk at C7, the effect of halogen at C8, and the effect of the C5-amino group were greatly influenced by the choice of the N1-substituent. Several outstanding broad spectrum quinolones were identified in this work. In particular, the spectrum and potency of the 7-piperazinyl quinolones could be greatly enhanced by the judicious choice of C5-, C8-, and N1-substitutents.
    DOI:
    10.1021/jm00107a039
点击查看最新优质反应信息

文献信息

  • 7-Azetidinylquinolones as Antibacterial Agents. 3. Synthesis, Properties and Structure-Activity Relationships of the Stereoisomers Containing a 7-(3-Amino-2-methyl-1-azetidinyl) Moiety
    作者:Jordi Frigola、David Vano、Antoni Torrens、Angels Gomez-Gomar、Edmundo Ortega、Santiago Garcia-Granda
    DOI:10.1021/jm00007a017
    日期:1995.3
    de]-1,4-benzoxazine-6-carboxylic acids was synthesized to study the effect of the azetidine moiety on tricyclic quinolone antibacterial agents. A series of amino acid prodrugs of chiral naphthyridines 24a and 24b and quinolone 33a (cetefloxacin) was prepared and evaluated for antibacterial activity, solubility, and pharmacokinetic behavior. The absolute configuration of the new azetidinylquinolones
    一系列立体化学纯的7-(3-氨基-2-甲基-1-氮杂环丁烷基)-1,4-二氢-6-氟-4-氧代喹啉-和-1,8-萘啶-3-羧酸制备了位于1、5和8位的取代基,以确定手性相对于外消旋混合物的效价和体内功效的影响(第2部分,参见:J. Med.Chem。1994,37, 4195-4210)。一系列手性9-氟-2,3-二氢-3-甲基-7-氧-10-(取代的1-氮杂环丁烷基)-7H-吡啶[1,2,3-de] -1,4-苯并恶嗪合成-6-羧酸以研究氮杂环丁烷部分对三环喹诺酮抗菌剂的作用。制备了一系列手性萘啶24a和24b以及喹诺酮33a(cetefloxacin)的氨基酸前药,并评估了其抗菌活性,溶解度和药代动力学行为。通过对拆分的氮杂环丁醇(15)和化合物25a(E-4767)的一种非对映异构盐进行X射线分析,可以确定新的氮杂环丁烷基喹诺酮类化合物的绝对构型,该化合物在体外和体内的总体情况最佳。
  • 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial
    申请人:Warner-Lambert Company
    公开号:US04822801A1
    公开(公告)日:1989-04-18
    Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.
    描述了新型萘啉基、喹啉基和苯并噁嗪羧酸作为抗菌剂的小说,以及它们的制造、配方和用于治疗细菌感染的方法,包括用于制造抗菌剂的某些新型中间体的描述。
  • Inhibitors of cellular efflux pumps of microbes
    申请人:WOCKHARDT LIMITED
    公开号:US20020177559A1
    公开(公告)日:2002-11-28
    Compounds are described which are efflux pump inhibitors of cellular efflux pumps of microbes. Also described are methods of preparing such compounds, methods of using such efflux pump inhibitor compounds and pharmaceutical compositions which include such compounds.
    描述了一些化合物,它们是微生物细胞外输泵的外输泵抑制剂。还描述了制备这些化合物的方法,使用这些外输泵抑制剂化合物的方法以及包括这些化合物的制药组合物。
  • Antibacterial agents - II
    申请人:Warner-Lambert Company
    公开号:US05097032A1
    公开(公告)日:1992-03-17
    Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the manufacture of the antibacterial agents.
    本文描述了新型萘啶、喹啉和苯并噁嗪羧酸作为抗菌剂,以及其制备、配方和治疗细菌感染的使用方法,包括制备抗菌剂所使用的某些新型中间体的描述。
  • Substituted-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acids, derivatives thereof, pharmaceutical compositions comprising the compounds, and processes for producing the compounds
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0265230A1
    公开(公告)日:1988-04-27
    Novel naphthyridine-, quinoline- and benzoxazinecarboxylic acids of formula in which Z is are disclosed. The compounds are useful as antibacterial agents. Also disclosed is a process for producing the compounds and a pharmaceutical composition comprising the compounds.
    新颖的萘啶、喹啉和苯并噁嗪羧酸,其式为 其中 Z 为 的新型萘啶-喹啉-和苯并噁嗪羧酸。这些化合物可用作抗菌剂。还公开了生产这些化合物的工艺和包含这些化合物的药物组合物。
查看更多